This infographic highlights the key benefits of being a member of AMCP for managed care professionals (a.k.a. MCPs) in different career settings.
AMCP Summary: 2018 Draft Call Letter
The Centers for Medicare and Medicaid Services (CMS) released 2018 Draft Call Letter on February 1, 2017. Overall, the Draft Call Letter does not contain any major changes that are of serious concern to managed care pharmacy. However, there are several provisions worth noting, such as changes to Star Ratings and efforts to reduce opioid overutilization, that AMCP is seeking feedback on from its members to inform the comments that will be submitted to CMS.
Related
The Access to Prescription Digital Therapeutics Act of 2023 will help ensure that the greatest number of patients possible are receiving innovative, modern care, which is especially vital for closing care gaps caused by specialist shortages or geographic obstacles. View the issue brief to learn more.
The Kidney Health Initiative convened a panel of experts in C3G to (1) assess the data supporting the use of the prespecified trial end points as measures of clinical benefit and (2) opine on efficacy findings they would consider compelling as treatment(s) of C3G in native kidneys. View the findings.
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
